NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Cancer Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . June 8th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Cancer Vaccine Week | Other Publications

Journal of the National Cancer Institute - New broad-spectrum vaccine to prevent cervical cancer induces strong responses in animals

University of Pennsylvania School of Medicine - Protein predicts development of invasive breast cancer in women with DCIS, Penn study shows

Cancer Vaccines - Reports from Army advance knowledge in cancer vaccines

Cancer Vaccines - Research conducted at N. Thiry and co-authors has provided new information about cancer vaccines

Cancer Vaccines - Research from Harvard University in the area of cancer vaccines described

Cancer Vaccines - Research from Mayo Clinic in the area of cancer vaccines published

Cancer Vaccines - Study results from Duke University broaden understanding of cancer vaccines

 ImmunoCellular Therapeutics, Ltd. - Clinical Data from Trial of ImmunoCellular Therapeutics’ Cancer Vaccine ICT-107 to Be Presented at ASCO 2009 Annual Meeting

Advaxis, Inc. - Advaxis Applies for $2.0 Million U.S. Bio-Defense Grant

Advaxis, Inc. - Advaxis Receives US Patent and Trademark Office Approval on Act-A Protein Patent-Pending Rights

Biovest International, Inc. - Personalized Anti-Cancer Vaccine Pivotal Phase III Results to be Presented at ASCO Plenary Session

Cancer Vaccines - Invitation: PROSTVAC(TM) Wrap up

Cancer Vaccines - PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide

Cancer Vaccines - Sexually Transmitted HPV Linked to Certain Head & Neck Cancers

Merck & Co. Inc. - GARDASIL® is First Cervical Cancer Vaccine to Receive WHO Pre-qualification

Research and Markets - Cancer Drug Discoveries: What the Future Holds for the Non-Small Cell Lung Cancer Market and Therapeutic Approaches


Return to Top of Page

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login